The introduction of off-patent semaglutide is set to reshape the treatment of diabetes. Previously restricted to branded formulations, this life-changing GLP-1 medication is now available to a wider number of people, potentially boosting outcomes and decreasing the expense for numerous who manage with the condition. This transition signifies a key